NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LYMPHOMA RESEARCH FOUNDATION, founded in 1991, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $14.2M in total revenue in fiscal year 2024. Net assets of $34.5M represent 29 months of operating reserves.
THE LYMPHOMA RESEARCH FOUNDATION'S MISSION IS TO REALIZE THE PROMISE OF SCIENCE TO ERADICATE LYMPHOMA AND SERVE THE COMMUNITY TOUCHED BY THIS DISEASE. BY BRINGING TOGETHER THE PROMISE OF SCIENCE AND THE POWER OF PEOPLE, A FUTURE WITHOUT LYMPHOMA IS WITHIN OUR REACH. THE FOUNDATION IS COMMITTED TO FUNDING THE MOST PROMISING LYMPHOMA RESEARCHERS AND ADVANCING THE UNDERSTANDING OF THE MORE THAN 100 DIFFERENT SUBTYPES OF LYMPHOMA. LRF'S DISEASE-SPECIFICITY AND HYPER-FOCUS ON FINDING CURES FOR EVERY TYPE OF LYMPHOMA ENSURE THE NEXT GENERATION OF CANCER RESEARCHERS DEDICATE THEIR CAREERS TO STUDYING LYMPHOMA, AND WORLD-LEADING LYMPHOMA EXPERTS COLLABORATE AND ACCELERATE THE PACE OF SCIENTIFIC DISCOVERY. THE FOUNDATION ALSO OFFERS A WIDE RANGE OF SUPPORT SERVICES, EDUCATIONAL PROGRAMS, AND FREE PUBLICATIONS FOR PEOPLE WITH LYMPHOMA AND THEIR CARE PARTNERS. THE FOUNDATION INVESTS MILLIONS OF DOLLARS ANNUALLY IN ITS MISSION, ALL MADE POSSIBLE BY DONATIONS FROM ITS SUPPORTERS. THE FOUNDATION IS SUPPORTED BY TENS OF THOUSANDS OF VOLUNTEERS AND DONORS WHO CONTRIBUTE THEIR TIME AND TALENTS TO THE ORGANIZATION. THE FOUNDATION HAS EARNED THE TRUST OF INDIVIDUAL, PRIVATE FOUNDATIONS, PUBLIC COMPANIES, AND ORGANIZATIONS THAT FUNS ITS WORK BY DEMONSTRATING A HISTORY OF CAREFUL AND PROVEN FINANCIAL STEWARDSHIP.
EDUCATIONAL PROGRAMS AND SUPPORT SERVICES - THE LYMPHOMA RESEARCH FOUNDATION OFFERS A WIDE RANGE OF EDUCATIONAL PROGRAMS AND SUPPORT SERVICES FOR LYMPHOMA PATIENTS AND THEIR LOVED ONES, INCLUDING...
EDUCATIONAL PROGRAMS AND SUPPORT SERVICES - THE LYMPHOMA RESEARCH FOUNDATION OFFERS A WIDE RANGE OF EDUCATIONAL PROGRAMS AND SUPPORT SERVICES FOR LYMPHOMA PATIENTS AND THEIR LOVED ONES, INCLUDING IN-PERSON AND VIRTUAL EDUCATION PROGRAMS AND EDUCATIONAL PUBLICATIONS. THE FOUNDATION HELPLINE PROVIDES LYMPHOMA PATIENTS AND THEIR LOVED ONES WITH INDIVIDUALIZED SUPPORT AND ANSWER ANY LYMPHOMA-RELATED QUESTIONS. THE FOUNDATION ALSO OFFERS A WIDE RANGE OF LYMPHOMA-FOCUSED EDUCATIONAL ACTIVITIES DESIGNED TO INCREASE THE KNOWLEDGE, SKILLS AND PERFORMANCE OF HEALTHCARE PROFESSIONALS AND TO MAXIMIZE THE QUALITY OF CARE FOR LYMPHOMA PATIENTS.
RESEARCH AND SCIENTIFIC PROGRAMS - THE LYMPHOMA RESEARCH FOUNDATION'S RESEARCH PROGRAM IS GUIDED BY ITS ELITE SCIENTIFIC ADVISORY BOARD, COMPRISED OF 45 EXPERT LYMPHOMA CLINICIANS AND SCIENTISTS FROM...
RESEARCH AND SCIENTIFIC PROGRAMS - THE LYMPHOMA RESEARCH FOUNDATION'S RESEARCH PROGRAM IS GUIDED BY ITS ELITE SCIENTIFIC ADVISORY BOARD, COMPRISED OF 45 EXPERT LYMPHOMA CLINICIANS AND SCIENTISTS FROM ACROSS NORTH AMERICA. THE FOUNDATION FUNDS RESEARCH INVESTIGATING EVERY LYMPHOMA SUBTYPE AND REMAINS COMMITTED TO SUPPORTING EARLY CAREER SCIENTISTS TO ENSURE THE BEST AND BRIGHTEST SCIENCE MINDS ARE DEDICATED TO RESEARCHING LYMPHOMA. IN ADDITION TO DIRECTLY FUNDING RESEARCH GRANTS, THE FOUNDATION FACILITATES COLLABORATION AND PARTNERSHIPS AMONG ACADEMIC SCIENTISTS, CLINICIANS, INDUSTRY, REGULATORY AGENCIES, AND PATIENTS. THROUGH ITS GLOBAL LYMPHOMA CONSORTIA AND SCIENTIFIC WORKSHOPS, THE FOUNDATION MOBILIZES THE RESEARCH COMMUNITY TO OVERCOME SYSTEMIC CHALLENGES AND SPEED THE PROGRESS OF THE DEVELOPMENT OF NEW TREATMENTS AND UNDERSTANDING OF THE VARIOUS SUBTYPES OF LYMPHOMA.
COMMUNITY OUTREACH AND ADVOCACY - THE LYMPHOMA RESEARCH FOUNDATION'S FOCUS INCLUDES COMMUNITY-BASED, PATIENT-CENTERED EDUCATION AND OUTREACH; INCREASING REPRESENTATION IN LYMPHOMA RESEARCH AND...
COMMUNITY OUTREACH AND ADVOCACY - THE LYMPHOMA RESEARCH FOUNDATION'S FOCUS INCLUDES COMMUNITY-BASED, PATIENT-CENTERED EDUCATION AND OUTREACH; INCREASING REPRESENTATION IN LYMPHOMA RESEARCH AND CLINICAL CARE AND COALESCING THE LYMPHOMA COMMUNITY AROUND AWARENESS INITIATIVES FOR THIS RARE DISEASE. THE FOUNDATION IS COMMITTED TO ADVOCATING ON BEHALF OF THE ENTIRE LYMPHOMA COMMUNITY IN SUPPORT OF THIS MISSION, WORKING COLLABORATIVELY WITH POLICYMAKERS, MEDICAL COMMUNITY, PATIENT ADVOCATES AND OTHER STAKEHOLDERS TO ADVANCE EFFORTS THAT WILL IMPROVE THE LIVES OF PEOPLE WITH LYMPHOMA. THE FOUNDATION SUPPORTS MEASURES WHICH WILL INCREASE FEDERAL FUNDING FOR LYMPHOMA RESEARCH AND ENSURE PATIENT ACCESS TO HIGH QUALITY CANCER CARE AND IMPROVED ANTI-CANCER TREATMENTS. THE FOUNDATION ALSO SUPPORTS EDUCATION AND OUTREACH EFFORTS TO IDENTIFY AND REACH UNDERSERVED PATIENT POPULATIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $14,181,182 | $13,925,738 | +0.0% |
| Expenses | $14,306,630 | $13,429,805 | +0.1% |
| Net Income | $-125,448 | $495,933 | -1.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JEFF BLOCK | VICE CHAIR AND TREASURER | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| KIM METCALF | VICE CHAIR | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| LEIGH OLSEN | SECRETARY | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| STEVEN EICHBERG | BOARD CHAIR | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| ANN LACASCE MD MMSC | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| ELLEN WALKER | BOARD MEMBER (EFF. 2/2025) | 1.0 |
Director
|
$0 | $0 | $0 |
| HARRIET GREENBERG | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| JOEL POLLICK | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| JOHN A NELSON | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| JOHN P LEONARD MD | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| KEVIN SHEA | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| KRISTI HENDRIKS | BOARD MEMBER (EFF. 7/2024) | 1.0 |
Director
|
$0 | $0 | $0 |
| LAURENCE DOBOSH | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| LINDSAY SPRINGER | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| MICHAEL FROY | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| MICHAEL WERNER | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| PATRICIA KANE | BOARD MEMBER (EFF. 6/2025) | 1.0 |
Director
|
$0 | $0 | $0 |
| PAUL MAJKOWSKI | BOARD MEMBER (EFF. 6/2025) | 1.0 |
Director
|
$0 | $0 | $0 |
| RAMESH SUBRAHMANIAN | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| ROBERT MCCAULEY | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| SCOTT PANSKY | BOARD MEMBER | 1.0 |
Director
|
$0 | $0 | $0 |
| WHITNEY NEIGHBORS | BOARD MEMBER (EFF. 2/2025) | 1.0 |
Director
|
$0 | $0 | $0 |
| HILLEL HYMAN | CHIEF OPERATING OFFICER (EFF. 12/2024) | 35.0 |
Officer
|
$14,808 | $0 | $14,808 |
| MEGHAN GUTIERREZ | CHIEF EXECUTIVE OFFICER | 45.0 |
Officer
|
$364,424 | $18,342 | $382,766 |
| LAURA WALLENSTEIN | CHIEF PHILANTHROPY OFFICER | 35.0 |
Key Emp
|
$235,033 | $45,347 | $280,380 |
| SARAH QUINLAN | CHIEF PROGRAM OFFICER | 35.0 |
Key Emp
|
$213,956 | $22,864 | $236,820 |
| CHRISTA BOGGIO | CONTROLLER | 45.0 |
Highest
|
$192,672 | $15,618 | $208,290 |
| LYNNE WINTER | SENIOR PHILANTHROPIC ADVISOR | 28.0 |
Highest
|
$153,446 | $14,531 | $167,977 |
| MICAH BANNER | SENIOR DIRECTOR, INDIVIDUAL GIVING | 35.0 |
Highest
|
$171,546 | $9,478 | $181,024 |
| NICHOLAS GUERCIO | SENIOR DIRECTOR, MARKETING & COMMUNICATION | 35.0 |
Highest
|
$181,070 | $12,528 | $193,598 |
| VICTOR GONZALEZ | SENIOR DIRECTOR, PATIENT PROGRAMS | 35.0 |
Highest
|
$170,659 | $20,699 | $191,358 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $14,181,182 | $14,306,630 | $42,720,239 | $-125,448 |
| 2024 | $13,925,738 | $13,429,805 | $42,834,039 | $495,933 |
| 2023 | $16,566,956 | $13,955,595 | $41,061,805 | $2,611,361 |
| 2022 | $14,709,927 | $12,900,895 | $35,546,178 | $1,809,032 |
| 2021 | $16,103,858 | $8,136,631 | $31,207,101 | $7,967,227 |
| 2020 | $13,944,952 | $8,171,393 | $22,709,643 | $5,773,559 |
| 2019 | $11,549,571 | $9,262,126 | $16,453,671 | $2,287,445 |
| 2018 | $10,020,837 | $8,461,312 | $13,738,328 | $1,559,525 |
Compare LYMPHOMA RESEARCH FOUNDATION with other nonprofits in New York and across the country.